{"id":"W2601978884","doi":"10.1200/jco.2013.31.15_suppl.e19509","title":"Prolonged therapy with single-agent bortezomib (btz) in four patients (pts) with relapsed primary systemic AL amyloidosis treated in the CAN2007 phase II study.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Adverse effect; Cumulative dose; AL amyloidosis; Maintenance therapy; Bortezomib; Phases of clinical research; Surgery; Clinical trial; Multiple myeloma; Chemotherapy; Antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001294162,0.000864464,0.001167122,0.0003038644,0.0004870586,0.000799973,0.0006426754,0.0008255297,0.0016484],"category_scores_gemma":[0.0007173444,0.0003602252,0.0006512518,0.0004600302,0.0006598309,0.0003922484,0.0004622619,0.00111588,0.0003127094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001663928,"about_ca_system_score_gemma":0.001134316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003073908,"about_ca_topic_score_gemma":0.007587471,"domain_scores_codex":[0.9996632,0.0001502746,0.000022371,0.0000472003,0.00003682268,0.00008010448],"domain_scores_gemma":[0.9994991,0.00007684559,0.00006169478,0.0000407563,0.00003184419,0.0002897775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5578119,0.06345507,0.1375525,0.001241875,0.003376266,0.005674164,0.001060292,0.0100751,0.06280205,0.0005169733,0.009003794,0.14743],"study_design_scores_gemma":[0.2524704,0.4993288,0.2240966,0.0000927508,0.001363712,0.004043902,0.0002601446,0.003686425,0.004937656,0.0002829691,0.009370694,0.00006586351],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972,0.00105418,0.0001401865,0.0001302354,0.0000230763,0.0003069738,0.0002591057,0.00002136343,0.0008648097],"genre_scores_gemma":[0.9971847,0.0004843628,0.0004173884,0.0002419013,0.00004831837,0.0002532491,0.0008890424,0.000006299641,0.0004747231],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003073908,"threshold_uncertainty_score":0.01207268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05651535327296212,"score_gpt":0.3699479900942198,"score_spread":0.3134326368212577,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}